Haplotype-specific effects on endothelial NO synthase promoter efficiency - Modifiable by cigarette smoking

被引:107
作者
Wang, R
Dudley, D
Wang, XL
机构
[1] SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78245 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Obstet & Gynecol, San Antonio, TX 78284 USA
关键词
gene; gene regulation; smoking; haplotypes; endothelial NO synthase;
D O I
10.1161/01.ATV.0000016248.51577.1F
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The T-786C promoter and 27-bp repeat intron 4 polymorphisms in the endothelial NO synthase (eNOS) gene have been inconsistently associated with various eNOS-related phenotypic changes. We explored molecular mechanisms underlying the inconsistency We constructed pGL3 luciferase reporter vectors by inserting an eNOS promoter fragment containing either T or C nucleotide at -786 bp at the 5' end of the luciferase coding region and eNOS intron 4 containing either 5X or 4x27-bp repeats at the 3' end of the luciferase gene. The transcription efficiency in the T promoter was lower than in the C promoter (15.7+/-1.0% vs 83.3+/-5.8%, P<0.01 when 5X27-bp was an enhancer and 37.6±4.7% vs 58.9±7.5%, P<0.01 when 4X27bp was an enhancer). Although cigarette smoking extracts treatment increased the transcription efficiency significantly in the T promoter (1.7-fold, P<0.01), it reduced the C promoter efficiency (by 10% to 15%). A mobility shift assay revealed positive binding of the 27-bp repeat fragment with endothelial cell nuclear protein extracts. Our study demonstrates a cis-acting role of the 27-bp repeats in eNOS promoter function and a haplotype-specific expression pattern determined by DNA variants at -786 bp and intron 4 of the eNOS gene that is also modifiable by cigarette smoking.
引用
收藏
页码:E1 / E4
页数:4
相关论文
共 20 条
[1]  
Cines DB, 1998, BLOOD, V91, P3527
[2]   Nitric oxide synthase: Role in the genesis of vascular disease [J].
Cooke, JP ;
Dzau, VJ .
ANNUAL REVIEW OF MEDICINE, 1997, 48 :489-509
[3]   Complex promoter and coding region β2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness [J].
Drysdale, CM ;
McGraw, DW ;
Stack, CB ;
Stephens, JC ;
Judson, RS ;
Nandabalan, K ;
Arnold, K ;
Ruano, G ;
Liggett, SB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (19) :10483-10488
[4]  
EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921
[5]   Acidic hydrolysis as a mechanism for the cleavage of the Glu298 → Asp variant of human endothelial nitric-oxide synthase [J].
Fairchild, TA ;
Fulton, D ;
Fontana, JT ;
Gratton, JP ;
McCabe, TJ ;
Sessa, WC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (28) :26674-26679
[6]   Polymorphisms in endothelial nitric oxide synthase and atherogenesis - John French Lecture 2000 [J].
Hingorani, AD .
ATHEROSCLEROSIS, 2001, 154 (03) :521-527
[7]  
Huang PL, 2000, J AM SOC NEPHROL, V11, pS120
[8]   HYPERTENSION IN MICE LACKING THE GENE FOR ENDOTHELIAL NITRIC-OXIDE SYNTHASE [J].
HUANG, PL ;
HUANG, ZH ;
MASHIMO, H ;
BLOCH, KD ;
MOSKOWITZ, MA ;
BEVAN, JA ;
FISHMAN, MC .
NATURE, 1995, 377 (6546) :239-242
[9]   Endothelial function and coronary artery disease [J].
Kinlay, S ;
Libby, P ;
Ganz, P .
CURRENT OPINION IN LIPIDOLOGY, 2001, 12 (04) :383-389
[10]   Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice [J].
Kuhlencordt, PJ ;
Gyurko, R ;
Han, F ;
Scherrer-Crosbie, M ;
Aretz, TH ;
Hajjar, R ;
Picard, MH ;
Huang, PL .
CIRCULATION, 2001, 104 (04) :448-454